Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 65 entries
Sorted by: Best Match Show Resources per page
Genetic homogeneity of adult Langerhans cell histiocytosis lesions: Insights from BRAF.

Oncology letters

Selway JL, Harikumar PE, Chu A, Langlands K.
PMID: 29085441
Oncol Lett. 2017 Oct;14(4):4449-4454. doi: 10.3892/ol.2017.6774. Epub 2017 Aug 18.

Langerhans cell histiocytosis (LCH) is a heterologous disease with a recognized disparity in incidence, affected sites and prognosis between adults and children. The recent identification of BRAF

[Nursing research as a basis for higher education].

Sykepleien

Langeland A.
PMID: 5190402
Sykepleien. 1968 Nov 15;55(22):658-60 passim.

No abstract available.

Anthropocene streams and base-level controls from historic dams in the unglaciated mid-Atlantic region, USA.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences

Merritts D, Walter R, Rahnis M, Hartranft J, Cox S, Gellis A, Potter N, Hilgartner W, Langland M, Manion L, Lippincott C, Siddiqui S, Rehman Z, Scheid C, Kratz L, Shilling A, Jenschke M, Datin K, Cranmer E, Reed A, Matuszewski D, Voli M, Ohlson E, Neugebauer A, Ahamed A, Neal C, Winter A, Becker S.
PMID: 21282157
Philos Trans A Math Phys Eng Sci. 2011 Mar 13;369(1938):976-1009. doi: 10.1098/rsta.2010.0335.

Recently, widespread valley-bottom damming for water power was identified as a primary control on valley sedimentation in the mid-Atlantic US during the late seventeenth to early twentieth century. The timing of damming coincided with that of accelerated upland erosion...

A novel automated image analysis method for accurate adipocyte quantification.

Adipocyte

Osman OS, Selway JL, Kępczyńska MA, Stocker CJ, O'Dowd JF, Cawthorne MA, Arch JR, Jassim S, Langlands K.
PMID: 23991362
Adipocyte. 2013 Jul 01;2(3):160-4. doi: 10.4161/adip.24652. Epub 2013 Apr 16.

Increased adipocyte size and number are associated with many of the adverse effects observed in metabolic disease states. While methods to quantify such changes in the adipocyte are of scientific and clinical interest, manual methods to determine adipocyte size...

Measurement of the branching ratio and asymmetry parameter for the Sigma +-->p gamma radiative decay.

Physical review. D, Particles and fields

Albuquerque IF, Bondar NF, Carrigan R, Chen D, Cooper PS, Denisov AS, Dobrovolsky AV, Dubbs T, Endler AM, Escobar CO, Foucher M, Golovtsov VL, Gottschalk H, Gouffon P, Grachev VT, Khanzadeev AV, Kubantsev MA, Kuropatkin NP, Lach J, Lang Pengfei, Langland J, Li Chengze, Li Yunshan, Lisheng D, Luksys M, Mahon JR, McCliment E, Morelos A, Newsom C, Pommot Maia MC, Samsonov VM, Schegelsky VA, Shi Huanzhang, Smith VJ, Tang Fukun, Terentyev NK, Timm S, Tkatch II, Uvarov LN, Vorobyov AA, Wenheng Z, Yan Jie, Zheng Shuchen, Zhong Yuanyuan.
PMID: 10018944
Phys Rev D Part Fields. 1995 May 01;51(9):4638-4660. doi: 10.1103/physrevd.51.4638.

No abstract available.

Postoperative pulmonary complications following major elective abdominal surgery: a cohort study.

Perioperative medicine (London, England)

Patel K, Hadian F, Ali A, Broadley G, Evans K, Horder C, Johnstone M, Langlands F, Matthews J, Narayan P, Rallon P, Roberts C, Shah S, Vohra R.
PMID: 27222707
Perioper Med (Lond). 2016 May 23;5:10. doi: 10.1186/s13741-016-0037-0. eCollection 2016.

BACKGROUND: Postoperative pulmonary complications (PPC) are an under-reported but major cause of perioperative morbidity and mortality. The aim of this prospective, contemporary, multicentre cohort study of unselected patients undergoing major elective abdominal surgery was to determine the incidence and...

Long-term Clinical Outcomes in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome.

Mayo Clinic proceedings. Innovations, quality & outcomes

Yap FHX, Olsson-White D, Roddy J, Cook NJ, Langlands DR, Manners PJ, Carroll GJ.
PMID: 34195549
Mayo Clin Proc Innov Qual Outcomes. 2021 May 10;5(3):574-582. doi: 10.1016/j.mayocpiqo.2021.02.009. eCollection 2021 Jun.

OBJECTIVE: To assess the outcome of empirical therapeutic interventions for synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome.METHODS: The clinical features and treatment outcomes of a cohort of 21 patients diagnosed with SAPHO in Western Australia were reviewed retrospectively.RESULTS:...

The Effect of Strip Grazing on Physical Activity and Behavior in Ponies.

Journal of equine veterinary science

Cameron A, Longland A, Pfau T, Pinnegar S, Brackston I, Hockenhull J, Harris PA, Menzies-Gow NJ.
PMID: 34972031
J Equine Vet Sci. 2021 Aug 19;110:103745. doi: 10.1016/j.jevs.2021.103745. Epub 2021 Aug 19.

This work aimed to determine the effect of strip grazing on physical activity in ponies using behavioral observations alongside accelerometers positioned at the poll. In study one, ten British native breed ponies were randomly assigned to paddock A (50...

IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer.

ESMO open

Molinier O, Besse B, Barlesi F, Audigier-Valette C, Friard S, Monnet I, Jeannin G, Mazières J, Cadranel J, Hureaux J, Hilgers W, Quoix E, Coudert B, Moro-Sibilot D, Fauchon E, Westeel V, Brun P, Langlais A, Morin F, Souquet PJ, Girard N.
PMID: 34953398
ESMO Open. 2021 Dec 22;7(1):100353. doi: 10.1016/j.esmoop.2021.100353. Epub 2021 Dec 22.

BACKGROUND: Immunotherapy using inhibitors targeting immune checkpoint programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) is currently the standard of care in patients with advanced non-small-cell lung cancer (NSCLC).MATERIALS AND METHODS: We carried out a nationwide cohort retrospective...

IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer.

ESMO open

Molinier O, Besse B, Barlesi F, Audigier-Valette C, Friard S, Monnet I, Jeannin G, Mazières J, Cadranel J, Hureaux J, Hilgers W, Quoix E, Coudert B, Moro-Sibilot D, Fauchon E, Westeel V, Brun P, Langlais A, Morin F, Souquet PJ, Girard N.
PMID: 34953398
ESMO Open. 2021 Dec 22;7(1):100353. doi: 10.1016/j.esmoop.2021.100353. Epub 2021 Dec 22.

BACKGROUND: Immunotherapy using inhibitors targeting immune checkpoint programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) is currently the standard of care in patients with advanced non-small-cell lung cancer (NSCLC).MATERIALS AND METHODS: We carried out a nationwide cohort retrospective...

Outcomes of Patients With Advanced NSCLC From the Intergroupe Francophone de Cancérologie Thoracique Biomarkers France Study by .

JTO clinical and research reports

Ruppert AM, Beau-Faller M, Debieuvre D, Ouafik L, Westeel V, Rouquette I, Mazières J, Bringuier PP, Monnet I, Escande F, Ricordel C, Merlio JP, Janicot H, Lemoine A, Foucher P, Poudenx M, Morin F, Langlais A, Souquet PJ, Barlesi F, Wislez M.
PMID: 34589947
JTO Clin Res Rep. 2020 May 15;1(3):100052. doi: 10.1016/j.jtocrr.2020.100052. eCollection 2020 Sep.

No abstract available.

Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer).

ESMO open

Bennouna J, Barlesi F, Do P, Dumont P, Cadranel J, Debieuvre D, Hilgers W, Molinier O, Quoix E, Raimbourg J, Langlais A, Morin F, Souquet PJ.
PMID: 30094074
ESMO Open. 2018 Jul 23;3(5):e000394. doi: 10.1136/esmoopen-2018-000394. eCollection 2018.

INTRODUCTION: This single-arm phase II trial aimed to evaluate a stop-and-go strategy with cisplatin-based chemotherapy and bevacizumab in advanced non-squamous non-small cell lung cancer (NSCLC).METHODS: Patients were initially treated with three cycles of pemetrexed, cisplatin plus bevacizumab (sequence 1)...

Showing 1 to 12 of 65 entries